Lymphoedema risk information
Inform all patients with breast cancer about the risk of developing lymphoedema and provide relevant information before treatment with surgery or radiation therapy.
Inform people with breast cancer about the risk of developing lymphoedema and give them relevant written information before treatment with surgery and radiotherapy
How this guidance was developed
This recommendation was adopted from the NICE 2018 guidelines (UK). The source recommendation was based on a systematic review of the evidence conducted to July 2008 and used wording ('give') indicative of a strong recommendation by the source guideline authors. The source recommendation was accepted with minor changes to the language to make it more applicable to the Australian health care context.
Lymphoedema risk information
Inform all patients with breast cancer about the risk of developing lymphoedema and provide relevant information before treatment with surgery or radiation therapy.
This recommendation was adopted from the NICE 2018 guidelines (UK). The source recommendation was based on a systematic review of the evidence conducted to July 2008 and used wording ('give') indicative of a strong recommendation by the source guideline authors. The source recommendation was accepted with minor changes to the language to make it more applicable to the Australian health care context.